HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dermcidin expression confers a survival advantage in prostate cancer cells subjected to oxidative stress or hypoxia.

AbstractBACKGROUND:
Dermcidin (DCD) is a candidate survival gene in breast cancer. DCD gene expression has been identified in prostate cancer cell lines and primary prostate cancer tissue. The DCD protein is composed of proteolysis-inducing factor-core peptide (PIF-CP) and the skin antimicrobial DCD-1. The aim of this work was to: (i) establish if the DCD gene confers resistance of prostate cancer cells to hypoxia and oxidative stress; (ii) identify the component of the gene transcript responsible for this effect.
METHODS:
Site-directed mutagenesis was used to create mutant DCD vectors. PC-3M prostate cancer cells were stably transfected with pcDNA3.1+ vectors encoding the entire DCD cDNA, mutant DCD vectors, or a control empty vector. Oxidative stress was produced using menadione, glucose oxidase, or hydrogen peroxide. Cell hypoxia was induced by incubation at 0.2% oxygen.
RESULTS:
Comparison of cell growth showed a 54.5% relative-proliferative advantage for the DCD-transfected PC-3M cells compared with sham-transfected cells after 8 days of cell growth (P = 0.03). Overexpression of DCD provided upto 36% absolute survival advantage over sham-transfected cells following induction of oxidative stress or hypoxia (P = 0.004). On exposure to hypoxia or oxidative stress PC-3M cells overexpressing the entire DCD gene had upto 42% survival advantage over those transfectants lacking the PIF-CP sequence (P = 0.004).
CONCLUSIONS:
DCD and PIF-CP are proliferation and survival factors in prostate cancer cells subjected to stressors found in the prostate cancer microenvironment. Thus, DCD and specifically PIF-CP are potential targets for the treatment of prostate cancer.
AuthorsGrant D Stewart, Alastair G Lowrie, Antony C P Riddick, Kenneth C H Fearon, Fouad K Habib, James A Ross
JournalThe Prostate (Prostate) Vol. 67 Issue 12 Pg. 1308-17 (Sep 01 2007) ISSN: 0270-4137 [Print] United States
PMID17626247 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Neoplasm
  • Nerve Tissue Proteins
  • Peptides
  • RNA, Neoplasm
  • dermcidin
Topics
  • Cell Death (genetics, physiology)
  • Cell Hypoxia (physiology)
  • Cell Line, Tumor
  • Cloning, Molecular
  • DNA, Neoplasm (chemistry, genetics)
  • Flow Cytometry
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • Male
  • Mutagenesis, Site-Directed
  • Nerve Tissue Proteins (biosynthesis, genetics)
  • Oxidative Stress (physiology)
  • Peptides
  • Prostatic Neoplasms (genetics, metabolism)
  • RNA, Neoplasm (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Statistics, Nonparametric
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: